Cases & Deals

  • Home
  • Practices
  • Hope Pharmaceuticals develops global patent portfolio relating to highly purified forms of sodium nitrite and sodium thiosulfate

Share

Hope Pharmaceuticals develops global patent portfolio relating to highly purified forms of sodium nitrite and sodium thiosulfate

July 2010

Client(s) Hope Pharmaceuticals

Jones Day represents Hope Pharmaceuticals in the establishment of a global patent portfolio related to highly purified forms of sodium nitrite and sodium thiosulfate relating to its FDA-approved cyanide antidote NITHIODOTE®.

Contacts

Before sending, please note:

Information on www.jonesday.com is for general use and is not legal advice. The mailing of this email is not intended to create, and receipt of it does not constitute, an attorney-client relationship. Anything that you send to anyone at our Firm will not be confidential or privileged unless we have agreed to represent you. If you send this email, you confirm that you have read and understand this notice.